Advertisement
Screener

DAVITA INC. (DVA) Cash and Cash Equivalents, Period Increase (Decrease)

2.0 / 5 stars · 43/110 Roast Me

DAVITA INC. Cash and Cash Equivalents, Period Increase (Decrease)

DAVITA INC. (DVA) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$225.28 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-23.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-02-23

  • DAVITA INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$158.21M.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was $134.11M.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$760.24M, a 414.16% decline year-over-year.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $559.04M.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$225.28M.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$585.93M, a 209.75% decline from fiscal 2015.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $533.88M, a 2711.05% increase from fiscal 2014.
  • DAVITA INC. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $18.99M, a 95.40% decline from fiscal 2013.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2017-12-31-$158.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
-$24.09M
derived: sum of 2 quarters · filed 2018-02-23
-$784.33M
derived: sum of 3 quarters · filed 2018-02-23
-$225.28M
10-K · filed 2018-02-23
2017-09-30$134.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$626.12M
derived: sum of 2 quarters · filed 2017-11-07
-$67.08M
10-Q · filed 2017-11-07
-$67.39M
derived: sum of 4 quarters · filed 2018-02-23
2017-06-30-$760.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
-$201.19M
10-Q · filed 2017-08-01
-$201.50M
derived: sum of 3 quarters · filed 2018-02-23
-$571.42M
derived: sum of 4 quarters · filed 2018-02-23
2017-03-31$559.04M
10-Q · filed 2017-05-02
$558.74M
derived: sum of 2 quarters · filed 2018-02-23
$188.82M
derived: sum of 3 quarters · filed 2018-02-23
$430.81M
derived: sum of 4 quarters · filed 2018-02-23
2016-12-31-$309.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
-$370.23M
derived: sum of 2 quarters · filed 2018-02-23
-$128.24M
derived: sum of 3 quarters · filed 2018-02-23
-$585.93M
10-K · filed 2018-02-23
2016-09-30-$369.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$127.93M
derived: sum of 2 quarters · filed 2017-11-07
-$585.62M
10-Q · filed 2017-11-07
-$133.92M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$241.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
-$215.70M
10-Q · filed 2017-08-01
$236.00M
derived: sum of 3 quarters · filed 2018-02-23
$349.68M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31-$457.69M
10-Q · filed 2017-05-02
-$5.99M
derived: sum of 2 quarters · filed 2018-02-23
$107.69M
derived: sum of 3 quarters · filed 2018-02-23
$30.16M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$451.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$565.38M
derived: sum of 2 quarters · filed 2018-02-23
$487.85M
derived: sum of 3 quarters · filed 2018-02-23
$533.88M
10-K · filed 2018-02-23
2015-09-30$113.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$36.15M
derived: sum of 2 quarters · filed 2016-11-02
$82.18M
10-Q · filed 2016-11-02
-$479.62M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30-$77.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$31.51M
10-Q · filed 2016-08-08
-$593.30M
derived: sum of 3 quarters · filed 2017-02-24
-$487.24M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$46.03M
10-Q · filed 2016-05-04
-$515.76M
derived: sum of 2 quarters · filed 2017-02-24
-$409.70M
derived: sum of 3 quarters · filed 2017-02-24
-$96.80M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31-$561.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
-$455.73M
derived: sum of 2 quarters · filed 2017-02-24
-$142.83M
derived: sum of 3 quarters · filed 2017-02-24
$18.99M
10-K · filed 2017-02-24
2014-09-30$106.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$418.97M
derived: sum of 2 quarters · filed 2015-11-05
$580.79M
10-Q · filed 2015-11-05
$556.34M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$312.90M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-05
$474.72M
10-Q · filed 2015-08-05
$450.28M
derived: sum of 3 quarters · filed 2016-02-26
$803.07M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$161.82M
10-Q/A · filed 2015-05-08
$137.38M
derived: sum of 2 quarters · filed 2016-02-26
$490.17M
derived: sum of 3 quarters · filed 2016-02-26
$408.40M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31-$24.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$328.35M
derived: sum of 2 quarters · filed 2016-02-26
$246.58M
derived: sum of 3 quarters · filed 2016-02-26
$412.50M
10-K · filed 2016-02-26
2013-09-30$352.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$271.02M
derived: sum of 2 quarters · filed 2014-11-06
$436.95M
10-Q · filed 2014-11-06
$588.50M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30-$81.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$84.16M
10-Q · filed 2014-08-01
$235.71M
derived: sum of 3 quarters · filed 2015-02-26
$344.46M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31$165.92M
10-Q · filed 2014-05-02
$317.48M
derived: sum of 2 quarters · filed 2015-02-26
$426.23M
derived: sum of 3 quarters · filed 2015-02-26
$250.38M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31$151.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
$260.30M
derived: sum of 2 quarters · filed 2015-02-26
$84.46M
derived: sum of 3 quarters · filed 2015-02-26
$140.00M
10-K · filed 2015-02-26
2012-09-30$108.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
-$67.10M
derived: sum of 2 quarters · filed 2013-11-06
-$11.56M
10-Q · filed 2013-11-06
-$159.01M
derived: sum of 4 quarters · filed 2014-02-21
2012-06-30-$175.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
-$120.31M
10-Q · filed 2013-08-07
-$267.76M
derived: sum of 3 quarters · filed 2014-02-21
-$456.38M
derived: sum of 4 quarters · filed 2014-02-21
2012-03-31$55.54M
10-Q · filed 2013-05-09
-$91.92M
derived: sum of 2 quarters · filed 2014-02-21
-$280.54M
derived: sum of 3 quarters · filed 2014-02-21
-$556.72M
derived: sum of 4 quarters · filed 2014-02-21
2011-12-31-$147.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21
-$336.07M
derived: sum of 2 quarters · filed 2014-02-21
-$612.26M
derived: sum of 3 quarters · filed 2014-02-21
-$466.37M
10-K · filed 2014-02-21
2011-09-30-$188.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31
-$464.80M
derived: sum of 2 quarters · filed 2012-10-31
-$318.91M
10-Q · filed 2012-10-31
$6.64M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30-$276.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$130.29M
10-Q · filed 2012-08-03
$195.26M
derived: sum of 3 quarters · filed 2013-03-01
$155.11M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31$145.89M
10-Q · filed 2012-05-02
$471.44M
derived: sum of 2 quarters · filed 2013-03-01
$431.29M
derived: sum of 3 quarters · filed 2013-03-01
$250.10M
derived: sum of 4 quarters · filed 2013-03-01
2010-12-31$325.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
$285.40M
derived: sum of 2 quarters · filed 2013-03-01
$104.21M
derived: sum of 3 quarters · filed 2013-03-01
$320.66M
10-K · filed 2013-03-01
2010-09-30-$40.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$221.34M
derived: sum of 2 quarters · filed 2011-11-04
-$4.89M
10-Q · filed 2011-11-04
-$47.12M
derived: sum of 4 quarters · filed 2012-07-06
2010-06-30-$181.19M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04
$35.26M
10-Q · filed 2011-08-04
-$6.96M
derived: sum of 3 quarters · filed 2012-07-06
$30.60M
derived: sum of 4 quarters · filed 2012-07-06
2010-03-31$216.45M
10-Q · filed 2011-05-06
$174.23M
derived: sum of 2 quarters · filed 2012-07-06
$211.80M
derived: sum of 3 quarters · filed 2012-07-06
$350.23M
derived: sum of 4 quarters · filed 2012-07-06
2009-12-31-$42.22M
derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06
-$4.65M
derived: sum of 2 quarters · filed 2012-07-06
$133.78M
derived: sum of 3 quarters · filed 2012-07-06
$128.58M
8-K · filed 2012-07-06
2009-09-30$37.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$176.00M
derived: sum of 2 quarters · filed 2010-11-05
$170.80M
10-Q · filed 2010-11-05
$193.73M
derived: sum of 4 quarters · filed 2011-02-25
2009-06-30$138.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05
$133.23M
10-Q · filed 2010-08-05
$156.17M
derived: sum of 3 quarters · filed 2011-02-25
$217.13M
derived: sum of 4 quarters · filed 2011-02-25
2009-03-31-$5.20M
10-Q · filed 2010-05-03
$17.74M
derived: sum of 2 quarters · filed 2011-02-25
$78.70M
derived: sum of 3 quarters · filed 2011-02-25
2008-12-31$22.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25
$83.89M
derived: sum of 2 quarters · filed 2011-02-25
-$36.16M
10-K · filed 2011-02-25
2008-09-30$60.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05
-$59.10M
10-Q · filed 2009-11-05
2008-06-30-$120.06M
10-Q · filed 2009-08-07
2007-12-31$136.84M
10-K · filed 2010-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43